Liver TransplantationTransplantation, HomologousKidney TransplantationBone Marrow TransplantationHematopoietic Stem Cell TransplantationHeart TransplantationTransplantation, AutologousLung TransplantationStem Cell TransplantationTransplantation ConditioningOrgan TransplantationGraft SurvivalGraft RejectionPancreas TransplantationIslets of Langerhans TransplantationTissue DonorsTransplantationTransplantation ImmunologyCell TransplantationTreatment OutcomeTransplantation ChimeraImmunosuppressive AgentsGraft vs Host DiseaseTransplantation, IsogeneicLiving DonorsTransplantation, HeterotopicRetrospective StudiesCord Blood Stem Cell TransplantationHeart-Lung TransplantationTime FactorsPostoperative ComplicationsTissue and Organ ProcurementTransplantation TolerancePeripheral Blood Stem Cell TransplantationLiver FailureImmunosuppressionHistocompatibility TestingFetal Tissue TransplantationRecurrenceSkin TransplantationFollow-Up StudiesWaiting ListsTransplantation, HeterologousMesenchymal Stem Cell TransplantationCorneal TransplantationHistocompatibilityHematologic NeoplasmsTissue TransplantationTacrolimusCadaverSurvival RateWhole-Body IrradiationCyclosporineSurvival AnalysisBrain Tissue TransplantationLiver DiseasesFacial TransplantationDonor SelectionOrgan PreservationRisk FactorsBusulfanProspective StudiesTransplantsKidney Failure, ChronicCombined Modality TherapyHLA AntigensLeukemiaPostoperative PeriodBronchiolitis ObliteransPatient SelectionTissue and Organ HarvestingAcute DiseaseAntilymphocyte SerumPrognosisLiverRemission InductionAnemia, AplasticHand TransplantationCytomegalovirus InfectionsBlood Group IncompatibilityMice, Inbred C57BLMycophenolic AcidHematopoietic Stem CellsMyeloablative AgonistsReoperationRats, Inbred LewCyclophosphamideAnastomosis, SurgicalBiopsyEnd Stage Liver DiseaseDisease-Free SurvivalNeoplasm TransplantationBrain DeathMelphalanPostoperative CareLiver Failure, AcuteLiver CirrhosisT-LymphocytesMultiple MyelomaCell Differentiation